How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
- PMID: 33363564
- PMCID: PMC7753050
- DOI: 10.3389/fgene.2020.491895
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Abstract
Many genetic variants in drug metabolizing enzymes and transporters have been shown to be relevant for treating psychiatric disorders. Associations are strong enough to feature on drug labels and for prescribing guidelines based on such data. A range of commercial tests are available; however, there is variability in included genetic variants, methodology, and interpretation. We herein provide relevant background for understanding clinical associations with specific variants, other factors that are relevant to consider when interpreting such data (such as age, gender, drug-drug interactions), and summarize the data relevant to clinical utility of pharmacogenetic testing in psychiatry and the available prescribing guidelines. We also highlight areas for future research focus in this field.
Keywords: cytochrome P450 enzymes; drug metabolism; drug transporters; pharmacogenomics (PGx); psychotropic drugs.
Copyright © 2020 Carvalho Henriques, Yang, Lapetina, Carr, Yavorskyy, Hague and Aitchison.
Conflict of interest statement
KA is a member of the Pharmacogene Variation Consortium, Clinical Pharmacogenetics Implementation Consortium, has received two research grants in the last two years from Janssen Inc., Canada (fellowship grants for trainees) and provided consultancy services (unpaid) for HLS Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Abilify - aripiprazole tablet (2016). Abilify - aripiprazole tablet. URL: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-4...
-
- Abilify 10 mg tablets. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/7969/smpc
-
- Abilify. Summary of Product Characteristics, European Medicines Agency Retrieved from https://www.ema.europa.eu/documents/product-information/abilify-epar-pro...
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
